Screening designs for drug development (Q5308154): Difference between revisions
From MaRDI portal
Changed an Item |
Normalize DOI. |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Property / DOI | |||
| Property / DOI: 10.1093/biostatistics/kxl031 / rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1093/biostatistics/kxl031 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2142233765 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q33259890 / rank | |||
Normal rank | |||
| Property / DOI | |||
| Property / DOI: 10.1093/BIOSTATISTICS/KXL031 / rank | |||
Normal rank | |||
Latest revision as of 16:40, 30 December 2024
scientific article; zbMATH DE number 5196095
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Screening designs for drug development |
scientific article; zbMATH DE number 5196095 |
Statements
Screening designs for drug development (English)
0 references
27 September 2007
0 references
backward induction
0 references
Bayesian optimal design
0 references
clinical trial design
0 references
forward simulation
0 references
utility function
0 references
